BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7788958)

  • 21. A randomized double-blind controlled trial of roxithromycin and cefaclor in the treatment of acute lower respiratory tract infections in general practice.
    Tilyard MW; Dovey SM
    Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):97S-101S. PubMed ID: 1617932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sulbactam/ampicillin in comparison with cefuroxime for infections of the lower respiratory tract. Results of a prospective, randomized comparative study].
    Schwigon CD; Cuhorst R; Gabor M; Zinndorf J; Springsklee M
    Med Klin (Munich); 1993 Jan; 88(1):16-20. PubMed ID: 8437527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cefaclor AF versus cefaclor in acute exacerbations of chronic bronchitis.
    Grossman RF
    Postgrad Med J; 1992; 68 Suppl 3():S30-6; discussion S36-7. PubMed ID: 1287616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ofloxacin in community-acquired lower respiratory infections. A comparison with amoxicillin or erythromycin.
    Stocks JM; Wallace RJ; Griffith DE; Garcia JG; Kohler RB
    Am J Med; 1989 Dec; 87(6C):52S-56S. PubMed ID: 2690620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cefodizime once daily in the treatment of lower respiratory tract infections.
    Piovano CF; Palombini BC; Dagrosa EE; Mendoza F; Facco EB
    Arzneimittelforschung; 1997 May; 47(5):674-7. PubMed ID: 9205786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefaclor: clinical and bacteriological evaluation in 45 cases.
    Gómez-Lus R; Martinez-Piriz R; Espinosa C; Guillen G; Gómez-Agudo G; Clavel A
    Postgrad Med J; 1979; 55 Suppl 4():70-1. PubMed ID: 44909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.
    Wilson R; Schentag JJ; Ball P; Mandell L;
    Clin Ther; 2002 Apr; 24(4):639-52. PubMed ID: 12017408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ
    Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemophilus influenzae bronchitis and pneumonia.
    Gleckman R; Hibert D
    Am Fam Physician; 1982 Nov; 26(5):153-7. PubMed ID: 6983289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection.
    Bradbury F
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():153-62. PubMed ID: 8396087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis.
    Gotfried MH; Ellison WT
    Am J Med; 1992 Apr; 92(4A):108S-113S. PubMed ID: 1316059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefaclor in the treatment of infective exacerbations of chronic bronchitis in cigarette smokers.
    Cazzola M; Franco C; Gioia V; Legnani D; Mancini V; Polverino M; Sevieri G
    J Chemother; 1991 Aug; 3(4):245-9. PubMed ID: 1779259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An open evaluation of the efficacy and safety of the new macrolide roxithromycin in the treatment of lower respiratory tract infections and pneumonia in Nigerian patients.
    Isah AO; Ohaju-Obodo J
    West Afr J Med; 1996; 15(2):111-6. PubMed ID: 8855675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections.
    Soepandi P; Mangunnegoro H; Yunus F; Gunawan J
    Respirology; 1998 Jun; 3(2):113-7. PubMed ID: 9692520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loracarbef versus cefaclor in the treatment of cystitis and asymptomatic bacteriuria.
    Iravani A
    Clin Ther; 1992; 14(1):54-63. PubMed ID: 1576626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
    Schleupner CJ; Anthony WC; Tan J; File TM; Lifland P; Craig W; Vogelman B
    Arch Intern Med; 1988 Feb; 148(2):343-8. PubMed ID: 3277562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clarithromycin and cefaclor suspensions in the treatment of acute otitis media in children.
    Gooch WM; Gan VN; Corder WT; Khurana CM; Andrews WP
    Pediatr Infect Dis J; 1993 Dec; 12(12 Suppl 3):S128-33. PubMed ID: 8295814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trials on pediatric lower-respiratory-tract infection: results and comments with cefetamet pivoxil.
    Paupe J; Sarbeji M; Scheinmann P; Delacourt C; Sorin M
    Chemotherapy; 1992; 38 Suppl 2():29-32. PubMed ID: 1516462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of doxycycline in acute infections of the lower respiratory tract.
    Lyons HA; Thomas JS; Heurich AE; Shepherd DA; Wetmore SD
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):24-31. PubMed ID: 1210
    [No Abstract]   [Full Text] [Related]  

  • 40. Randomized comparative study of ceftibuten versus cefaclor in the treatment of acute lower respiratory tract infections.
    Kammer RB; Ress R
    Diagn Microbiol Infect Dis; 1991; 14(1):101-5. PubMed ID: 2013204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.